Episode 17: Peanut Oral Immunotherapy

As the first peanut oral immunotherapy product undergoes consideration for FDA approval, many in the allergy field and their patients are seeking to learn more. In this recorded episode for the AAAAI podcast series, Conversations from the World of Allergy, the host (David Stukus) will interview food allergy expert Julie Wang, MD FAAAAI regarding peanut oral immunotherapy and cover topics including the efficacy data from clinical trials, the regimen, risks, and benefits. Practical aspects such as patient considerations, cost, and a comparison with off-label peanut oral immunotherapy will be discussed as well.

You must listen to Episode 17: Peanut Oral Immunotherapy before continuing. Return to this window to continue with the assessment and claim credit.

Target Audience

  • Allergist/immunologists
  • Fellows-in-Training
  • Nurses and Nurse Practitioners
  • Physician Assistants and Other Allied Health Professionals
  • Patients/Patients' Families

Learning Objectives

Upon completion of this course, the learner will be able to:

  1. Identify current research findings regarding the efficacy of peanut oral immunotherapy
  2. Explain the risks, benefits, and regimen surrounding peanut oral immunotherapy
  3. Outline the practical aspects of peanut oral immunotherapy
Related Resources

The Current State of Oral Immunotherapy (OIT) for the Treatment of Food Allergy

Available credit: 
  • 0.75 Attendance
    Attendance credit.
  • 0.75 CME
    CME credit.
Course opens: 
Course expires: 

Planning Committee 
David R. Stukus, MD FAAAAI
Nationwide Children's Hospital, Columbus, OH
Relevant relationships: Aimmune Therapeutics: Consultant for a non-promotional, non-CME event

Julie Wang, MD MS FAAAAI
Icahn School of Medicine at Mount Sinai, New York, NY
Relevant relationships: ALK Abello: DMC; DBV Technologies and Aimmune: Research Grant Funding Recipient; DBV Technologies: Advisory Board Member

Content Reviewers 
Gloria Akan, MD
ENTAA Care, Glen Burnie, MD
Relevant relationships: None

Andrew D. Moore, MD FAAAAI
ENTAA Care, Glen Burnie, MD
Relevant relationships: None

AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement 
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period 
Credit claiming for this activity will expire at 11:59 pm on October 20, 2020. Requests to claim credit after October 20, 2020 will be denied.

Medium and Method of Physician Participation 
Follow these steps to complete the activity:

  1. Listen to the podcast episode.
  2. Review the information in the Faculty and Accreditation tabs.
  3. Click Begin.
  4. Complete the assessment. You must achieve a score of 70% or higher to claim credit.
  5. Complete the activity evaluation.
  6. Claim your credits.
  7. Print or save your certificate.

AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Activity-related questions should be directed to cme@aaaai.org

Available Credit

  • 0.75 Attendance
    Attendance credit.
  • 0.75 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.